{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:24:44Z","timestamp":1790623484275,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T00:00:00Z","timestamp":1466812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s12016-016-8566-3","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T05:40:52Z","timestamp":1466919652000},"page":"323-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNF\u03b1 Treatment"],"prefix":"10.1007","volume":"52","author":[{"given":"Ivica","family":"Laz\u00farov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-2820","authenticated-orcid":false,"given":"\u013dubom\u00edr","family":"Tom\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,25]]},"reference":[{"issue":"3","key":"8566_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4(3):130\u2013136","journal-title":"Autoimmun Rev"},{"issue":"11","key":"8566_CR2","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/rheumatology\/ket253","volume":"52","author":"S Norton","year":"2013","unstructured":"Norton S, Sacker A, Dixey J, Done J, Williams P, Young A (2013) Early rheumatoid arthritis study. Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality. Rheumatology (Oxford) 52(11):2016\u20132024","journal-title":"Rheumatology (Oxford)"},{"key":"8566_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00591","volume":"6","author":"KA Schuett","year":"2015","unstructured":"Schuett KA, Lehrke M, Marx N, Burgmaier M (2015) High risk cardiovascular patients: clinical features, comorbidities and interconnecting mechanisms. Front Immunol 6:1\u20139","journal-title":"Front Immunol"},{"issue":"2","key":"8566_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","volume":"46","author":"A Young","year":"2007","unstructured":"Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S et al (2007) Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatol (Oxford) 46(2):350\u2013357","journal-title":"Rheumatol (Oxford)"},{"key":"8566_CR5","first-page":"445","volume":"24","author":"S Wallberg-Johnsson","year":"1997","unstructured":"Wallberg-Johnsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24:445\u2013451","journal-title":"J Rheumatol"},{"key":"8566_CR6","doi-asserted-by":"publisher","unstructured":"Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafstrom I et al. (2016) Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but different cause of death in patients with rheumatoid arthritis: a longitudinal study in three European cohort. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2015-208579 .","DOI":"10.1136\/annrheumdis-2015-208579"},{"issue":"1","key":"8566_CR7","doi-asserted-by":"publisher","first-page":"e0146991","DOI":"10.1371\/journal.pone.0146991","volume":"11","author":"G Crepaldi","year":"2016","unstructured":"Crepaldi G, Scire CA, Carrara G, Sakellariou G, Caporali R, Hmamouchi I et al (2016) Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis. PLoS One 11(1):e0146991. doi: 10.1371\/journal.pone.0146991","journal-title":"PLoS One"},{"issue":"1","key":"8566_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13075-016-0928-y","volume":"18","author":"L Innala","year":"2016","unstructured":"Innala L, Sjoberg C, Moller B, Ljung L, Smedby T, Sodergren A et al (2016) Co-morbidity in patients with early rheumatoid arthritis-inflammation matters. Arthritis Res Ther 18(1):33. doi: 10.1186\/s13075-016-0928-y","journal-title":"Arthritis Res Ther"},{"key":"8566_CR9","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1002\/art.20612","volume":"50","author":"H Maradit-Kremers","year":"2004","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatism 50:3450\u20133456","journal-title":"Arthritis Rheumatism"},{"key":"8566_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden death in rheumatoid arthritis. Arthritis Rheum 52:402\u2013410","journal-title":"Arthritis Rheum"},{"key":"8566_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3899\/jrheum.090670","volume":"37","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Giles JT, Polak JF, Blumenthal RS, Leffell MS, Szklo M et al (2010) Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery specific. J Rheumatol 37:730\u2013739","journal-title":"J Rheumatol"},{"key":"8566_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/ar1814","volume":"7","author":"JT Giles","year":"2005","unstructured":"Giles JT, Fernandes V, Lima JAC, Bathon JM (2005) Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7:195\u2013207","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"8566_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","volume":"8","author":"NA Ntusi","year":"2015","unstructured":"Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8(5):526\u2013536","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"8566_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/1381612820666140825123407","volume":"21","author":"L Rodriguez-Rodriguez","year":"2015","unstructured":"Rodriguez-Rodriguez L, Lopez-Mejias R, Fernandez-Gutierez B, Balsa A, Gonzales-Gay MA, Martin J (2015) Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease. Curr Pharm Des 21(2):182\u2013201","journal-title":"Curr Pharm Des"},{"key":"8566_CR15","first-page":"1695","volume":"34","author":"N Kumar","year":"2007","unstructured":"Kumar N, Marshall NJ, Hammal DM, Pearce MS, Parker L, Furniss SS et al (2007) Causes of death in patients with rheumatoid arthritis: comparison with siblings and matched osteoarthritis controls. J Rheumatol 34:1695\u20131698","journal-title":"J Rheumatol"},{"key":"8566_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","volume":"116","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors and the effects of anti tumor necrosis factor therapy. Am J Med 116:305\u2013311","journal-title":"Am J Med"},{"issue":"5","key":"8566_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3899\/jrheum.120941","volume":"40","author":"SS McCoy","year":"2013","unstructured":"McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger V, Matteson EL, Gabriel SE (2013) Long-term outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 40(5):605\u2013610. doi: 10.3899\/jrheum.120941","journal-title":"J Rheumatol"},{"key":"8566_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2474-14-147","volume":"14","author":"S Rostom","year":"2013","unstructured":"Rostom S, Mengat M, Lahlou R, Hari A, Bahim R, Hassouni NH (2013) Metabolic syndrome in rheumatoid arthritis: case control study. BMC Musculosceletal Dis 14:147","journal-title":"BMC Musculosceletal Dis"},{"key":"8566_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13075-015-0549-x","volume":"17","author":"F Parra-Salcedo","year":"2015","unstructured":"Parra-Salcedo F, Contreras-Y\u00e1\u00f1ez I, El\u00edas-L\u00f3pez D, Aguilar-Salinas CA, Pascual-Ramos V (2015) Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity. Arthritis Res Ther 17:34. doi: 10.1186\/s13075-015-0549-x","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8566_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4082\/kjfm.2016.37.1.44","volume":"37","author":"SH Lee","year":"2016","unstructured":"Lee SH, Choi H, Cho BL, An AR, Seo YG, Jin HS et al (2016) Relationship between metabolic syndrome and rheumatoid arthritis. Korean J Fam Med 37(1):44\u201350. doi: 10.4082\/kjfm.2016.37.1.44","journal-title":"Korean J Fam Med"},{"issue":"10","key":"8566_CR21","doi-asserted-by":"publisher","first-page":"e78151","DOI":"10.1371\/journal.pone.0078151","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Fu L, Shi J, Chen X, Li Y, Ma B, Zhang Y (2013) The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One 8(10):e78151. doi: 10.1371\/journal.pone.0078151","journal-title":"PLoS One"},{"key":"8566_CR22","first-page":"115","volume":"33","author":"P Jiang","year":"2015","unstructured":"Jiang P, Li H, Li X (2015) Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol 33:115\u2013121","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"8566_CR23","doi-asserted-by":"publisher","first-page":"e101528","DOI":"10.1371\/journal.pone.0101528","volume":"9","author":"MC Lu","year":"2014","unstructured":"Lu MC, Yan ST, Yin WY, Koo M, Lai NS (2014) Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study. PLoS One 9(7):e101528. doi: 10.1371\/journal.pone.0101528","journal-title":"PLoS One"},{"issue":"7","key":"8566_CR24","doi-asserted-by":"publisher","first-page":"e2552","DOI":"10.1097\/MD.0000000000002552","volume":"95","author":"F Ursini","year":"2016","unstructured":"Ursini F, Russo E, D\u2019Angelo S, Arturi F, Hribal ML, D\u2019Antona L et al (2016) Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT study. Medicine (Baltimore) 95(7):e2552. doi: 10.1097\/MD.0000000000002552","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"8566_CR25","doi-asserted-by":"publisher","first-page":"e0117952","DOI":"10.1371\/journal.pone.0117952","volume":"10","author":"LR Baghdadi","year":"2015","unstructured":"Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA (2015) The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 10(2):e0117952. doi: 10.1371\/journal.pone.0117952","journal-title":"PLoS One"},{"key":"8566_CR26","first-page":"2475","volume":"26","author":"SE Gabriel","year":"1999","unstructured":"Gabriel SE, Crowson CS, O\u2019Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475\u20132479","journal-title":"J Rheumatol"},{"issue":"5","key":"8566_CR27","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar428","volume":"4","author":"PH Dessein","year":"2002","unstructured":"Dessein PH, Stanwix AE, Joffe BI (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4(5):R5","journal-title":"Arthritis Res"},{"issue":"9","key":"8566_CR28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107(9):1303\u20131309","journal-title":"Circulation"},{"issue":"6","key":"8566_CR29","first-page":"900","volume":"33","author":"X Yang","year":"2015","unstructured":"Yang X, Gao F, Liu Y (2015) Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis. Clin Exp Rheumatol 33(6):900\u2013903","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"8566_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/ajh\/hpv119","volume":"29","author":"K Hamamoto","year":"2016","unstructured":"Hamamoto K, Yamada S, Yasumoto M, Yoda M, Yoda K, Tsuda A et al (2016) Association of nocturnal hypertension with disease activity in rheumatoid arthritis. Am J Hypertens 29(3):340\u2013347. doi: 10.1093\/ajh\/hpv119","journal-title":"Am J Hypertens"},{"issue":"14","key":"8566_CR31","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1097\/MD.0000000000000731","volume":"94","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Hong D, Zhang Y, Sang Y, Yang Z, Zhang X (2015) Association between anti-TNF therapy for rheumatoid arthritis and hypertension: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94(14):e731. doi: 10.1097\/MD.0000000000000731","journal-title":"Medicine (Baltimore)"},{"key":"8566_CR32","first-page":"2597","volume":"28","author":"SW Jonsson","year":"2011","unstructured":"Jonsson SW, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Dahlqvist SR (2011) Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 28:2597\u20132602","journal-title":"J Rheumatol"},{"key":"8566_CR33","first-page":"1","volume":"14","author":"R Sakai","year":"2015","unstructured":"Sakai R, Hirano F, Kihara M, Yokoyama W, Yamazaki H, Harada S et al (2015) High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. Mod Rheumatol 14:1\u20137","journal-title":"Mod Rheumatol"},{"issue":"10","key":"8566_CR34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/acr.22029","volume":"65","author":"E Myasoedova","year":"2013","unstructured":"Myasoedova E, Gabriel SE, Green AB, Matteson EL, Crowson CS (2013) Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken) 65(10):1592\u20131599","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8566_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/ard.2010.141523","volume":"70","author":"SA Provan","year":"2011","unstructured":"Provan SA, Semb AG, Hisdal J, Stranden E, Aqewall S, Dagfinud H et al (2011) Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis 70:812\u2013817","journal-title":"Ann Rheum Dis"},{"key":"8566_CR36","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","volume":"44","author":"E Hurt-Camejo","year":"2001","unstructured":"Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B et al (2001) Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 44:2761\u20132767","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8566_CR37","first-page":"BC01","volume":"9","author":"VU Chavan","year":"2015","unstructured":"Chavan VU, Ramavataram D, Patel PA, Rupani MP (2015) Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. J Clin Diagn Res 9(4):BC01\u2013BC05","journal-title":"J Clin Diagn Res"},{"issue":"8","key":"8566_CR38","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/art.39165","volume":"67","author":"KP Liao","year":"2015","unstructured":"Liao KP, Liu J, Lu B, Solomon DH, Kim SC (2015) Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis Rheumatol 67(8):2004\u20132010","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8566_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3899\/jrheum.140694","volume":"42","author":"A S\u00f6dergren","year":"2015","unstructured":"S\u00f6dergren A, Karp K, Bengtsson C, M\u00f6ller B, Rantap\u00e4\u00e4-Dahlqvist S, W\u00e5llberg-Jonsson S (2015) The extent of subclinical atherosclerosis is partially predicted by the inflammatory load: a prospective study over 5 years in patients with rheumatoid arthritis and matched controls. J Rheumatol 42(6):935\u2013942","journal-title":"J Rheumatol"},{"key":"8566_CR40","doi-asserted-by":"publisher","unstructured":"Ahmed A, Hollan I, Curran SA, Kitson SM, Riggio MP, Mikkelsen K et al. (2016) Rheumatoid arthritis patients have a pro-atherogenic cytokine microenvironment in the aortic adventitia. Arthritis Rheumatol. doi: 10.1002\/art.39574","DOI":"10.1002\/art.39574"},{"issue":"6","key":"8566_CR41","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/annrheumdis-2013-205058","volume":"74","author":"I Rinc\u00f3n del","year":"2015","unstructured":"del Rinc\u00f3n I, Polak JF, O\u2019Leary DH, Battafarano DF, Erikson JM, Restrepo JF et al (2015) Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis 74(6):1118\u20131123","journal-title":"Ann Rheum Dis"},{"key":"8566_CR42","doi-asserted-by":"publisher","first-page":"523897","DOI":"10.1155\/2014\/523897","volume":"2014","author":"D Kuo","year":"2014","unstructured":"Kuo D, Crowson CS, Gabriel SE, Matteson EL (2014) Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis. Int J Rheumatol 2014:523897. doi: 10.1155\/2014\/523897","journal-title":"Int J Rheumatol"},{"issue":"12","key":"8566_CR43","doi-asserted-by":"publisher","first-page":"e0144932","DOI":"10.1371\/journal.pone.0144932","volume":"10","author":"KI Maijer","year":"2015","unstructured":"Maijer KI, Neumann E, M\u00fcller-Lander U, Drop DACAD, Ramwadhdoeve TH, Choi IYK et al (2015) Serum Vaspin levels are associated with the development of clinically manifest arthritis in autoantibody-positive individuals. PLoS One 10(12):e0144932","journal-title":"PLoS One"},{"issue":"1","key":"8566_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/art.21560","volume":"54","author":"PJ Nicola","year":"2006","unstructured":"Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54(1):60\u201367","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8566_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"PJ Nicola","year":"2005","unstructured":"Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52(2):412\u2013420","journal-title":"Arthritis Rheum"},{"key":"8566_CR46","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3899\/jrheum.141647","volume":"42","author":"T Schau","year":"2015","unstructured":"Schau T, Gottwald M, Arbach O, Seifert M, Schopp M, Neuss M et al (2015) Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type. J Rheumatol 42:2029\u20132037","journal-title":"J Rheumatol"},{"issue":"2","key":"8566_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/1529-0131(200104)45:2<129::AID-ANR164>3.0.CO;2-K","volume":"45","author":"C Guedes","year":"2001","unstructured":"Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC (2001) Cardiac manifestation of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum 45(2):129\u2013135","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8566_CR48","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3899\/jrheum.100979","volume":"38","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL et al (2011) The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 38(8):1601\u20131606","journal-title":"J Rheumatol"},{"key":"8566_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.23281","volume":"58","author":"J Listing","year":"2008","unstructured":"Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A (2008) Does tumor necrosis factor-\u03b1 inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58:667\u2013677","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8566_CR50","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1191\/0961203305lu2220oa","volume":"14","author":"P Sarzi-Puttini","year":"2005","unstructured":"Sarzi-Puttini P, Atzueni F, Doria A, Iaccarino L, Turiel M (2005) Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 14(9):780\u2013784","journal-title":"Lupus"},{"key":"8566_CR51","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.amjcard.2007.03.048","volume":"100","author":"AC Roldan","year":"2007","unstructured":"Roldan AC, DeLong C, Qualls CR, Crawford MC (2007) Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates. Am J Cardiol 100:496\u2013502","journal-title":"Am J Cardiol"},{"key":"8566_CR52","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar3752","volume":"14","author":"JT Giles","year":"2012","unstructured":"Giles JT, Fert-Bober J, Park JK, Bingham CO 3rd, Andrade F, Fox-Talbot K et al (2012) Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther 14:R39","journal-title":"Arthritis Res Ther"},{"key":"8566_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/ard.59.3.227","volume":"59","author":"M Franco Di","year":"2000","unstructured":"Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L et al (2000) Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis 59:227\u2013229","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8566_CR54","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/ard.2009.124362","volume":"69","author":"KP Liang","year":"2010","unstructured":"Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL et al (2010) Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 69(9):1665\u20131670","journal-title":"Ann Rheum Dis"},{"issue":"9-10","key":"8566_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00508-013-0349-8","volume":"125","author":"L Tom\u00e1\u0161","year":"2013","unstructured":"Tom\u00e1\u0161 L, Laz\u00farov\u00e1 I, Oetterov\u00e1 M, Pundov\u00e1 L, Petr\u00e1\u0161ov\u00e1 D, Studen\u010dan M (2013) Left ventricular morphology and function in patients with rheumatoid arthritis. Wien Klin Wochenschr 125(9-10):233\u2013238","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"8566_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.15537\/smj.2015.5.10751","volume":"36","author":"R Sakthiswary","year":"2015","unstructured":"Sakthiswary R, Das S (2015) Predictors of diastolic dysfunction in rheumatoid arthritis. Saudi Med J 36(5):525\u2013529","journal-title":"Saudi Med J"},{"key":"8566_CR57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacc.2005.10.059","volume":"47","author":"GS Bhatia","year":"2006","unstructured":"Bhatia GS, Sosin MD, Patel JV, Grindulis KA, Khattak FH, Huighes EA et al (2006) Left ventricular systolic dysfunction in rheumatoid disease. An unrecognized burden? J Am Coll Cardiol 47:1169\u20131174","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"8566_CR58","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00059-015-4320-5","volume":"40","author":"G Cioffi","year":"2015","unstructured":"Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S et al (2015) Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz 40(7):989\u2013996","journal-title":"Herz"},{"issue":"9","key":"8566_CR59","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.autrev.2014.05.007","volume":"13","author":"PE Lazzerini","year":"2014","unstructured":"Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13(9):936\u2013944","journal-title":"Autoimmun Rev"},{"key":"8566_CR60","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1136\/bmj.e1257","volume":"344","author":"J Lindhardsen","year":"2012","unstructured":"Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH et al (2012) Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 344:e1257","journal-title":"BMJ"},{"key":"8566_CR61","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/art.23796","volume":"58","author":"J Solus","year":"2008","unstructured":"Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A et al (2008) Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 58:2662\u20132669","journal-title":"Arthritis Rheum"},{"key":"8566_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/03009740310003686","volume":"32","author":"A Yxfeldt","year":"2003","unstructured":"Yxfeldt A, Wallberg-Jonsson S, Hultdin J, Rantap\u00e4\u00e4-Dahlqvist S (2003) Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 32:205\u2013210","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"8566_CR63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10741-009-9140-3","volume":"15","author":"B Bozkurt","year":"2009","unstructured":"Bozkurt B, Mann DL, Deswal A (2009) Biomarkers of inflammation in heart failure. Heart Fail Rev 15(4):331\u2013341","journal-title":"Heart Fail Rev"},{"issue":"25","key":"8566_CR64","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","volume":"102","author":"M Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C et al (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102(25):3060\u20133067","journal-title":"Circulation"},{"issue":"16","key":"8566_CR65","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","volume":"103","author":"A Deswal","year":"2001","unstructured":"Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055\u20132059","journal-title":"Circulation"},{"key":"8566_CR66","first-page":"1044","volume":"103","author":"B Bozkurt","year":"2001","unstructured":"Bozkurt B, Torre-Amione G, Smith Warren M, Soran OZ, Feldman AM, Mann DL (2001) Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Am J Assoc 103:1044\u20131047","journal-title":"Am J Assoc"},{"key":"8566_CR67","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Anti-TNF Therapy Against Congestive Heart Failure Investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133\u20133140","journal-title":"Circulation"},{"key":"8566_CR68","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1388-9842(02)00039-9","volume":"4","author":"AP Coletta","year":"2002","unstructured":"Coletta AP, Clark AL, Banarjee P, Cleland JG (2002) Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur J Heart Fail 4:243\u2013247","journal-title":"Eur J Heart Fail"},{"key":"8566_CR69","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/art.23280","volume":"58","author":"SE Gabriel","year":"2008","unstructured":"Gabriel SE (2008) Tumor necrosis factor inhibition: a part of the Solution or a part of the problem of heart failure in rheumatoid arthritis. Arthritis Rheum 58:637\u2013640","journal-title":"Arthritis Rheum"},{"key":"8566_CR70","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/art.20164","volume":"50","author":"D Khanna","year":"2004","unstructured":"Khanna D, McMahon M, Furst DE (2004) Anti tumor necrosis factor-\u03b1 therapy and heart failure. Arthritis Rheum 50:1040\u20131048","journal-title":"Arthritis Rheum"},{"key":"8566_CR71","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.3899\/jrheum.110751","volume":"39","author":"PJ Kotyla","year":"2012","unstructured":"Kotyla PJ, Owczarek A, Rakoczy J, Lewicki M, Kucharz EJ, Emery P (2012) Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin-1, interleukin 6 and NT-probrain natriuretic peptide. J Rheumatol 39:4701\u20134706","journal-title":"J Rheumatol"},{"issue":"1","key":"8566_CR72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10067-012-2091-4","volume":"32","author":"L Tom\u00e1\u0161","year":"2013","unstructured":"Tom\u00e1\u0161 L, Laz\u00farov\u00e1 I, Pundov\u00e1 L, Oetterov\u00e1 M, Zakuciov\u00e1 M, Petr\u00e1\u0161ov\u00e1 D, Studen\u010dan M (2013) Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases. Clin Rheumatol 32(1):61\u201366","journal-title":"Clin Rheumatol"},{"key":"8566_CR73","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/rheumatology\/kem212","volume":"46","author":"JR Curtis","year":"2007","unstructured":"Curtis JR, Kramer JM, Martin C, Saag KG, Patkar N, Shatin D et al (2007) Heart failure among younger rheumatoid arthritis and Crohn\u2019s patients exposed to TNF-\u03b1 antagonists. Rheumatol 46:1688\u20131693","journal-title":"Rheumatol"},{"key":"8566_CR74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.trsl.2010.09.005","volume":"157","author":"Z Al-Aly","year":"2011","unstructured":"Al-Aly Z, Pan H, Zeringue A, Xian H, McDonald JR, El-Achkar TM, Eisen S (2011) Tumor necrosis factor-\u03b1 blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. Transl Res 157:10\u201316","journal-title":"Transl Res"},{"key":"8566_CR75","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1590\/S0104-42302012000600015","volume":"58","author":"RC Santos","year":"2012","unstructured":"Santos RC, Figueiredo VN, Martinz LC, Haro Moraes C, Quinaglia T, Boer-Martins L et al (2012) Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure. Rev Assoc Med Bras 58:698\u2013702","journal-title":"Rev Assoc Med Bras"},{"issue":"7","key":"8566_CR76","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/ard.2009.119412","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N, Nurmohamed MT (2010) Tumour necrosis factor alpha blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Ann Rheum Dis 69(7):1281\u20131285","journal-title":"Ann Rheum Dis"},{"key":"8566_CR77","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","volume":"156","author":"S Setoguchi","year":"2008","unstructured":"Setoguchi S, Schneeweiss S, Avorn J, Katz JN, Weinblatt M, Levin R et al (2008) Tumor necrosis factor-\u03b1 antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J 156:336\u2013341","journal-title":"Am Heart J"},{"key":"8566_CR78","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/annrheumdis-2012-202136","volume":"72","author":"DH Solomon","year":"2013","unstructured":"Solomon DH, Rassen JA, Kuriva B, Chen L, Harrold LR, Graham DJ et al (2013) Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist. Ann Rheum Dis 72:1813\u20131818","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8566_CR79","first-page":"CD008794","volume":"16","author":"JA Singh","year":"2011","unstructured":"Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK et al (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 16(2):CD008794","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"8566_CR80","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2177\/jsci.37.488","volume":"37","author":"A Suzuki","year":"2014","unstructured":"Suzuki A, Tamamura T, Okai T (2014) Five-year administration of tocilizumab to a patient with rheumatoid arthritis complicated by severe chronic heart failure. Jpn J Clin Immunol 37(6):488\u2013492","journal-title":"Jpn J Clin Immunol"},{"key":"8566_CR81","doi-asserted-by":"publisher","unstructured":"Kobayashi Y, Kobayashi H, Giles JT, Hirano M, Nakajima Y, Takei M (2015) Association of tocilizumab with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis. doi: 10.1111\/1756-185X.12632","DOI":"10.1111\/1756-185X.12632"},{"key":"8566_CR82","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.107.731877","volume":"117","author":"I Ikonomidis","year":"2008","unstructured":"Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T et al (2008) Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117:2662\u20132669","journal-title":"Circulation"},{"key":"8566_CR83","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/hrt.2009.168971","volume":"95","author":"I Ikonomidis","year":"2009","unstructured":"Ikonomidis I, Tzortzis S, Lekakis J, Paraskevaidis I, Andreadou I, Nikolaou M et al (2009) Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis. Heart 95:1502\u20131507","journal-title":"Heart"},{"key":"8566_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/CIRCIMAGING.113.001193","volume":"7","author":"I Ikonomidis","year":"2014","unstructured":"Ikonomidis I, Tzortzis S, Andreadou I, Paraskevaidis I, Katseli C, Katsimbri P et al (2014) Increased benefit of Interleukin -1 inhibition on vascular function, myocardial deformation and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circ Cardiovasc Imaging 7:619\u2013628","journal-title":"Circ Cardiovasc Imaging"},{"key":"8566_CR85","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/art.10870","volume":"48","author":"RM Fleischamnn","year":"2003","unstructured":"Fleischamnn RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J et al (2003) Anakinra, a recombinant human interleukin-1 receptor antagonist, (r-metHuIL-1ra) in patients with rheumatoid arthritis. Arthritis Rheumatism 48:927\u2013934","journal-title":"Arthritis Rheumatism"},{"key":"8566_CR86","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","volume":"111","author":"A Abbate","year":"2013","unstructured":"Abbate A, Van Tassel BW, Biondi-Zoccai G, Kontos MC, Grizzard JD, Spilmann DW et al (2013) Effects of Interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction (from the Virginia commonwealth University-Anakinra remodeling Trial (2)(VCU-ART2) pilot study). J Cardiol 111:1394\u20131400","journal-title":"J Cardiol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-016-8566-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8566-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T22:24:33Z","timestamp":1718663073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-016-8566-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,25]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["8566"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8566-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,25]]}}}